Results 181 to 190 of about 25,935 (265)

Supplementary Figure S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

Lena Fischer‐Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, Katja Petry, Andreas Bosio, Angelika von Döllen, Wolfgang Hartmann, Holger N. Lode, Dennis Görlich, Andréas Mackensen, Melanie Jungblut, Axel Schambach, Hinrich Abken, Claudia Rössig   +20 more
openalex   +1 more source

Fe-doping-driven enhancement of electronic conductivity and electrocatalytic performance in Gd₂O₃ nanoparticles for ultrasensitive electrochemical detection of chloramphenicol in pharmaceutical and milk samples. [PDF]

RSC Adv
Nguyen TA, An Nguyen NH, Dinh NX, Thanh Tam LT, Quang NX, Lu LT, Phan MH, Le AT.   +7 more
europepmc   +1 more source

Supplemental Figure 4 from GD2-Targeting CAR T-cell Therapy for Patients with GD2⁺ Medulloblastoma

Roselia Ciccone, Concetta Quintarelli, Antonio Camera, Michele Pezzella, Simona Caruso, Simona Manni, Alessio Ottaviani, Marika Guercio, Francesca Del Bufalo, Maria Cecilia Quadraccia, Domenico Orlando, Stefano Di Cecca, Matilde Sinibaldi, Mariasole Aurigemma, Laura Iaffaldano, Andrea Sarcinelli, Maria Luisa D'Amore, Manuela Ceccarelli, Francesca Nazio, Veronica Marabitti, Ezio Giorda, Marco Pezzullo, Cristiano De Stefanis, Andrea Carai, Sabrina Rossi, Rita Alaggio, Giada Del Baldo, Marco Becilli, Angela Mastronuzzi, Biagio De Angelis, Franco Locatelli   +30 more
openalex   +1 more source

Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating

, 2000
Rong‐Long Chen, C. Patrick Reynolds, Robert C. Seeger   +2 more
openalex   +2 more sources

CAR T cells for pediatric CNS tumors: Clinical experience and reverse translational opportunities. [PDF]

Mol Ther Oncol
Song KW, Kaur AP, Ramakrishna S.
europepmc   +1 more source

ANTITUMOR ACTIVITY AND PHENOTYPIC PROPERTIES OF GD2-SPECIFIC CAR T CELLS IN VITRO AND IN VIVO

Philippova J.G., Julia Shevchenko, M.S. Fisher, S. Alrhmoun, Roman Perik-Zavodskii, Olga Perik-Zavosdkaia, Julia Lopatnikova, V.V. Kurilin, Marina Volynets, A. Alsalloum, E. L. Zavjalov, O.I. Solovjeva, Hiroshi Shiku, А. Н. Силков, С. В. Сенников   +14 more
openalex   +1 more source

IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells

, 2017
Venkata Lokesh Battula, Khoa Nguyen, Jeff Sun, Mary Kathryn Pitner, Bin Yuan, Chandra Bartholomeusz, Numsen Hail, Michael Andreeff   +7 more
openalex   +2 more sources

CAR T cells targeting the glycoprotein GD2 show potent antitumor efficacy in high-risk ependymoma models. [PDF]

J Clin Invest
Tallon-Cobos AC, Vazaios K, Waranecki P, van Hoesel M, Cornel A, Schwalm B, Mack N, de Boed E, van der Lugt J, Nierkens S, Kool M, Hoving EW, Metselaar DS, Hulleman E.   +13 more
europepmc   +1 more source

Supplementary Methods S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

Lena Fischer‐Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, Katja Petry, Andreas Bosio, Angelika von Döllen, Wolfgang Hartmann, Holger N. Lode, Dennis Görlich, Andréas Mackensen, Melanie Jungblut, Axel Schambach, Hinrich Abken, Claudia Rössig   +20 more
openalex   +1 more source

Ganglioside therapy in cancer molecular insights and therapeutic opportunities. [PDF]

Discov Oncol
Banerjee A, Banerjee S, Maity SR, Das A.
europepmc   +1 more source